Invesco NASDAQ Biotech UCITS ETF Acc

Invesco NASDAQ Biotech UCITS ETF Acc

5.8
Overall
Compare ETFs

$60.79 — 2026-03-30T22:00:00.000Z

52-week high: $63.09 (2026-02-23T23:00:00.000Z)

52-week low: $39.18 (2025-04-09T22:00:00.000Z)

DateNAV
2021-04-06T22:00:00.000Z$47.72
2021-10-17T22:00:00.000Z$49.83
2022-05-10T22:00:00.000Z$34.66
2022-11-27T23:00:00.000Z$43.34
2023-06-21T22:00:00.000Z$43.22
2024-01-07T23:00:00.000Z$46.78
2024-07-30T22:00:00.000Z$50.11
2025-02-19T23:00:00.000Z$47.76
2025-09-10T22:00:00.000Z$50.46
2026-03-30T22:00:00.000Z$60.79

Past performance doesn't indicate future results
Fund Size €363M
Distribution Re-Invests Dividends
Replication Synthetic
Inception Nov 2014
Base Currency USD
Index NASDAQ Biotechnology Index TR
Asset Class Equities

Costs

6.8
This fund has moderate costs compared to similar ETFs.

Cost Metrics Explained

What TER, tracking difference, and TD consistency measure

TER (Total Expense Ratio) is the annual fee the fund charges, deducted from assets. It’s the headline cost, but not the full picture.

Tracking Difference measures how much the fund actually lags (or leads) its benchmark index per year. This is the single best measure of true cost — it captures TER plus all other drags like sampling error and tax withholding. A lower (or negative) value is better.

TD Consistency measures how stable the tracking difference is from year to year. A low value means predictable, reliable costs; a high value means costs can vary significantly.
TER0.00%
Tracking Difference0.00%
TD Consistency0.00%

Cumulative Returns

Performance across different time periods.
1 Month+0.00%
3 Months+0.00%
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%

Holdings

5.3
This fund holds 256 individual investments, offering moderate diversification compared to other ETFs.
#1
Gilead Sciences Inc
7.74%
#2
Amgen Inc
7.50%
#3
Vertex Pharmaceuticals Inc
7.44%
#4
Regeneron Pharmaceuticals Inc
6.45%
#5
Alnylam Pharmaceuticals Inc
3.53%
#6
Insmed Inc
2.83%
#7
Biogen Inc
2.16%
#8
United Therapeutics Corp
2.09%
#9
ARGENX SE - ADR
1.67%
#10
Royalty Pharma PLC
1.65%

Sectors

1.0
This fund is concentrated in just a few of its 2 sectors, reducing diversification.

Regions

5.0
This fund invests across 5 countries, though its geographic allocation deviates somewhat from the global market.

Documents

Regulatory and fund documents.
Key Information DocumentFact Sheet

Broker Availability

Where you can buy this ETF.
Trading 212
Trade
Free
Savings Plan
Free
Account
Free
flatex
Trade
€5.90
Savings Plan
Free
Account
Free

Similar ETFs

Other funds tracking Thematic Equity indices.
Xtrackers Artificial Intelligence & Big Data UCITS ETF 1C
IE00BGV5VN51·TER 0.35%
6.9
iShares Automation & Robotics UCITS ETF
IE00BYZK4552·TER 0.40%
7.3
iShares Global Clean Energy Transition UCITS ETF
IE00B1XNHC34·TER 0.65%
7.3
iShares Global Water UCITS ETF
IE00B1TXK627·TER 0.65%
6.8
iShares Global Infrastructure UCITS ETF
IE00B1FZS467·TER 0.65%
7.5
Amundi MSCI Water UCITS ETF Dist
FR0010527275·TER 0.60%
6.4
Feedback
ETFs
Basket
Compare
Millennial Index